Tag: Mydecine - Page 6 - Psychedelic Alpha

Read more about the article Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Post published:April 26, 2021
Post category:Press Release

Read more about the article Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Post published:April 13, 2021
Post category:Press Release

Read more about the article Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Post published:April 7, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Migration to NEO Exchange

Mydecine Innovations Group Announces Migration to NEO Exchange

Post published:March 23, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Provides Update on European Operations

Mydecine Innovations Group Provides Update on European Operations

Post published:March 16, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Post published:March 10, 2021
Post category:Press Release

Read more about the article Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Post published:March 1, 2021
Post category:Press Release

Read more about the article Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Post published:February 24, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Post published:February 17, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

Post published:February 12, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.